The rise of multi-drug resistant (MDR) and extensively drug resistant tuberculosis is threatening to outdo years of progress in controlling the disease.
Bolstering the know how behind targeted cancer treatment, Indian scientists have offered a new rationale for combination drug therapy for ovarian and breast cancer, which they say can counter drug resistance and reduce side-effects.
Trials show new drug could kill parasite and prevent the spread of malaria, which kills over half a million a year, and would cost around $1 per treatment.
Experts are expressing concerns that antibiotics are losing their effectiveness at an increasing rate. Antibiotic resistance has become one of the most significant threats to patients' safety.
Vaccination to prevent the disease is not currently in widespread use in these countries; instead the disease is controlled mainly through use of anti-microbial drugs.
TB is treatable, however, the bacteria that cause TB can develop resistance to the antimicrobial drugs used to cure the disease. This is known as Drug-Resistant TB or Multidrug-resistant TB (MDR-TB).
A centuries-old herbal Chinese medicine, used to effectively treat malaria, may help fight tuberculosis and slow the evolution of drug resistance, scientists have found.